August 14, 2015
The Brooklyn federal judge overseeing vitamin C price-fixing litigation said Friday he was tempted to place two Chinese judgment debtors into receivership as plaintiffs expressed frustration at their inability to collect on a damages award approaching $160 million in value.
April 17, 2015
Two Chinese companies urged a New York federal judge Friday to deny a bid by a group of U.S. businesses to sanction them for refusing to turn over financial documents in a vitamin C price-fixing suit, saying the Chinese government has prohibited them from doing so.
March 23, 2015
A group of U.S. businesses urged a New York federal judge to sanction two Chinese companies, saying each has refused to turn over financial documents after being hit with a verdict that topped $150 million in a vitamin C price-fixing suit.
January 02, 2014
A New York federal judge on Monday added $4 million in attorneys' fees to the $153 million price-fixing verdict against vitamin C company North China Pharmaceutical Group Corp. and awarded the plaintiffs interest.
December 16, 2013
Weisheng Pharmaceutical Co. Ltd. and parent company CSPC Pharmaceutical Group Ltd., formerly known as China Pharmaceutical Group Ltd., have agreed to pay $2.2 million to settle with consumers and other indirect purchasers over claims that they conspired to fix vitamin C prices, the plaintiffs said Friday.
November 26, 2013
A New York federal judge on Tuesday refused to toss a $153.3 million award against Hebei Welcome Pharmaceutical Co. Ltd. and North China Pharmaceutical Group Corp. in a class action over vitamin C price-fixing claims, finding a jury wasn't improperly blocked from evidence.
October 03, 2013
A New York federal judge on Wednesday approved a $10 million attorney award and granted final approval to a $23 million settlement that allowed China Pharmaceutical Group Ltd. to step out of a class action over vitamin C price-fixing claims.
June 03, 2013
North China Pharmaceutical Group Corp. urged a New York federal court Friday to toss a $153 million damages award against the company because the recent vitamin C price-fixing trial improperly passed judgment on the Chinese government's export policies.
May 13, 2013
The class alleging North China Pharmaceutical Group Corp. and its vitamin C unit fixed prices pushed back Friday against NCPG's bid to dismiss the suit in New York federal court and toss a recent $153 million damages award, saying China didn't compel the companies' illegal conduct.
April 11, 2013
North China Pharmaceutical Group Corp. on Thursday asked a New York federal judge to vacate a recent $153 million award and dismiss multidistrict antitrust litigation alleging illegal collusion in China's vitamin C industry, claiming that only NCPG's indirectly owned subsidiary was involved in the scheme.